This document discusses scale up techniques for sterile products like parenteral and ophthalmic products. It explains the importance of pilot plants in examining formulas and processing equipment before full scale production. Key aspects of scaling up parenteral products are formulation considerations like choice of solvents, solubilizers, buffers and sterilization methods. Proper facilities are required for different production stages from clean up to filling to ensure sterility. Formulation and quality control testing factors for ophthalmic products are also outlined. Maintaining sterile conditions is essential throughout the manufacturing process of these sterile dosage forms.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
Glass as a packaging material in pharmaceutical packagingShweta Shelke
This presentation gives a brief idea about the types of glasses used in pharmaceutical industry and its intended use. Different tests used for assuring its quality for intended use.
Introduction to Quality control tests for ophthalmics
Introduction, Universal tests, Quality control test
Presented by
T.Jayasree
Pharmaceutical analysis
Physics of Tablet compression is very useful during study of the tablet. It contains the mechanism of tablet compression. It also contains the process of tablet compression.
Parenteral,Sterile, Aseptic condition
Air classification, Quantitative layout of parental manufacturing, Equipment as per schedule-M
Environmental control zone
presented by: Eknath Vasant Unde
Rajarambapu college of pharmacy kasegaon sangali
Introduction to Quality control tests for ophthalmics
Introduction, Universal tests, Quality control test
Presented by
T.Jayasree
Pharmaceutical analysis
Physics of Tablet compression is very useful during study of the tablet. It contains the mechanism of tablet compression. It also contains the process of tablet compression.
Parenteral,Sterile, Aseptic condition
Air classification, Quantitative layout of parental manufacturing, Equipment as per schedule-M
Environmental control zone
presented by: Eknath Vasant Unde
Rajarambapu college of pharmacy kasegaon sangali
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
Aseptic process technology & advanced sterile product manufacturing technology it is done for doing in process quality control test for sterile product
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Aseptic requirements for parenteral products".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
MANUFACTURING OF PARENTRALS
1. Formulation and Raw Materials:
Concept: The process begins with the formulation of the parenteral drug, determining its composition and concentration.
Raw Materials: High-quality pharmaceutical-grade raw materials, including active pharmaceutical ingredients (APIs), excipients, and solvents, are selected based on their compatibility and purity.
2. Sterilization of Raw Materials:
Concept: Due to the sterile nature of parenteral products, all raw materials, including the API and excipients, must undergo rigorous sterilization.
Methods: Common sterilization methods include autoclaving, filtration, and aseptic processing to ensure aseptic conditions throughout the manufacturing process.
3. Manufacturing Process:
Preparation: The formulation is prepared, and various components are weighed and measured precisely.
Mixing: The ingredients are mixed under controlled conditions to achieve a homogeneous blend, ensuring uniform distribution of the API and other components.
Filtration: The solution is then filtered to remove any particulate matter and ensure clarity.
Filling: The sterile drug solution is filled into vials, ampoules, or other suitable containers in a controlled environment, maintaining sterility.
4. Sterilization of Final Product:
Terminal Sterilization: The final product, in its container, undergoes terminal sterilization methods like autoclaving or gamma irradiation to eliminate any microbial contamination that may have occurred during the manufacturing process.
Designing of aseptic area, laminar flow equipment: Study of different source ...Ms. Pooja Bhandare
Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification. PHARMACEUTICALMICROBIOLOGY (BP303T)Unit-IVPart-1
Introduction: Designing of Aseptic Area . i) The clean-up area,
ii) The compounding area,
iii) The aseptic area,
iv) The quarantine area and
v) The packaging/labelling area.
Flow diagram of aseptic area. Floors, walls and ceilings, Doors, windows and services Personnel and protective clothing Cleaning and disinfection. Air Supply. Laminar flow equipment. Vertical laminar air flow bench
Horizontal laminar air flow bench
High Efficiency Particulate Air (HEPA) Filter. Operating Instructions Uses of Laminar Air Flow.Advantages of Laminar Air Flow.Limitations of Laminar Air Flow. Air flow pattern Unidirectional airflow
Non-unidirectional airflow
Combined airflow
Different Sources of Contamination in an Aseptic Area
1) Personnel:
2) Buildings and Facilities
3) Equipment and Utensils:
4) Raw Materials
5) Manufacturing Process:
Methods of Prevention of Contamination Clean Area Classification
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Scale up techniques in the production of sterile products & ophthalmic products
1. Seminor on
Scale Up Techniques In The Production Of Sterile
Products And Ophthalmic Products
DEPARTMENT OF PHAEMACEUTICS
2. INTRODUCTION
PILOT PTANT:
It is defined as a part of pharmaceutical industry where
a lab scale formula is transformed into a product by the
development of procedure for manufacturing.
R & D Production
SCALE UP:
It is defined as the art of designing of prototype using
the data obtained from the pilot plant.
3. Importance of Pilot Plant:
Examination of formulae.
Review of range of relevant processing equipments.
The specification of the raw materials.
Production rates.
The physical space required.
Appropriate records and reports to support GMP.
4. SCALE UP OF PARENTRAL PRODUCTS
para: outside
enteron: intestine (i.e. beside the intestine)
These are the preparations which are given other than oral routes.
Injections:
These are
Sterile,
Pyrogen free preparations intended to be administered
parenterally (outside alimentary tract).
6. Formulation aspects
Solvent:
solvent used for parenteral production is water for injection.
WFI is prepared by distillation or reverse osmosis. Sterile water for
injection is used as a vehicle for reconstitution of sterile solid products
before administration and is terminally sterilized by autoclaving
Water miscible vehicles:
Ethyl alcohol, PEG, PG
Non aqueous vehicles:
Fixed oils
7. Solubilizing agents used in sterile products include:
1. co-solvents: glycerine, ethanol, sorbitol, etc.
2. Surface active agents: polysorbate 80, polysorbate 20, lecithin.
3. Complexing agents: cyclodextrins etc
They act by reducing the dielectric constant properties of the solvent
system, thereby reducing the electrical, conductance capabilities of the
solvent and thus increase the solubility.
Solubilizers:
They are used to enhance and maintain the aqueous solubility of
poorly water-soluble drugs.
8. Antimicrobial agents:
Added for fungistatic or bacteriostat action or concentration
Used to prevent the multiplication of micro-organisms
Ex..
• Benzyl alcohol
• Benzethonium chloride
• Methyl paraben
Preservatives:
• Multidose containers must have preservatives unless prohibited by
monograph.
• Large volume parenteral must not contain preservative becoz it may be
dangerous to human body if it contain in high doses.
9. Buffers:
They are used to maintain the pH level of a solution in the range that
provides either maximum stability of the drug against hydrolytic
degradation or maximum or optimal solubility of the drug in solution.
Exampies:Acetic acid , benzoic acid, citric acid, lactic acid
Antioxidants:
Antioxidants function by reacting prefentially with molecular oxygen and
minimizing or terminating the free radical auto-oxidation reaction.
Examples: phenol (0.065-0.5%), m-cresol (0.16-0.3%) etc.
Chelating agents:
Used to form the complex with the metallic ions present in the
formulation so that the ions will not interfere during mfg. of
formulation.
They form a complex which gets dissolved in the solvents.
Examples:
Disodium edetate , Disodium calcium edetate
10. Stabilizers:
As parenterals are available in solution form they are most prone to
unstabilize
Used to stabilize the formulation
Maintain stable
Examples:
Creatinine , Glycerin
Tonicity- adjusting agents:
Used to reduce the pain of injection.
Buffers may acts as tonicity contributor as well as stabilizers for the
pH.
Isotonicity depends on permeability of a living semipermaeable
membrane
• Hypotonic : swelling of cells (enlargement)
• Hypertonic: shrinking of cells (reduction)
Example:
Glycerin ,Lactose , Mannitol
15. Sterilization and Depyrogenation
Steam sterilization
Dry-heat sterilization and depyrogenation
Gas and vapour sterilization
Radiation sterilization
Sterilization by filteration
17. Clean- up area:
Non aseptic area
Free from dust ,fibres & micro-organisms
Constructed in such a way that should withstand moisture, steam &
detergent
Ceiling & walls are coated with material to prevent accumulation of
dust & micro-organisms
Exhaust fans are fitted to remove heat & humidity
The area should be kept clean so that to avoid contamination to aseptic
area
The containers & closures are washed & dried in this area.
18. Preparation area:
The ingredients are mixed & preparation is prepared for filling
Not essential that the area is aseptic
Strict precaution is taken to prevent contamination from outside
Cabinets & counters: SS
Ceiling & walls : sealed & painted
Aseptic area:
Filtration & filling into final containers & sealing is done
The entry of outside person is strictly prohibited
To maintain sterility, special trained persons are only allowed to enter & work
Person who worked should wear sterile cloths
Should be subjected for physical examination to ensure the fitness
Minimum movement should be there in this area
Ceiling & walls & floors : sealed & painted or treated with aseptic solution and
there should not be any toxic effect of this treatment
19. Cabinets & counters: SS
Mechanical equipments : SS
AIR:
• Free from fibres, dust & micro organisms
• HEPA filters are used which removes particles upto 0.3
micron
• Fitted in laminar air flow system, in which air is free
from dust & micro organisms flows with uniform
velocity
• Air supplied is under positive pressure which prevents
particulate contamination from sweeping
• UV lamps are fitted to maintain sterility
20. Quarantine area:
After filling, sealing & sterilization the products or batch
is kept in this area
The random samples are chosen and given for analysis to
QC dept.
The batch is send to packing after issuing satisfactory
reports of analysis from QC
If any problem is observed in above analysis the decision
is to be taken for reprocessing or others..
21. Finishing and packaging area:
After proper label, the product is given for packing
Packing is done to protect the product from external
environment
The ideal Packing is that which protects the product during
transportation, storage, shipping & handling.
The labeled container should be packed in cardboard or
plastic containers
Ampoules should be packed in partitioned boxes.
22. Opthalmic Solutions
Ophthalmic preparations are sterile product that are
intended to be applied to the eyelids or placed in the
space between eyelids or placed in the space
between the eye lids and the eyeball
23. Ideal property for ophthalmic preparation
Sterility. (Avoidance of pyrogens )
Preservation.
Tissue compatibility.
Suitable packaging.
Must be isotonic with lacrymical fluids.
should have P H approx 7.4.
viscosity.
24. Types of ophthalmic dosage forms
1)Solutions-
ADVANTAGES DISADVANTAGES
convenience - rapid corneal elimination.
- loss of drug by drainage.
- No sustained action
2) Suspensions-
ADVANTAGES DISADVANTAGES
- patient compliance loss of both solution
- slow dissolution & suspended solid.
25.
26. FORMULATION
(1) Vehicles:
There are two types of vehicles which are:
Aqueous vehicles:-
e.g. Water is used as vehicle because water is tolerated well by the
body
Non-aqueous vehicles:-
e.g. Oils and Alcohols, such as, fixed oils, almond oil, ethyl alcohol,
propylene glycol.
30. VARIOUS FACTORS AFFECTING STABILITY OF
FORMULATIONS
Temperature.
pH.
Excipients.
Oxidation.
Light.
packaging.
31. Manufacturing considerations
Manufacturing Environment:
The environment should be sterile and particle-free
through: -
Laminar-flow should be used throughout the
manufacturing area.
Relative humidity controlled to between 40 and 60%.
Walls, ceilings and floors should be constructed of
materials that are hard, non flaking, smooth and non-
affected by surface cleaners or disinfectants.
32.
33.
34. MANUFACTURING OPERATION
1) AREA REQUIREMENT
• Minimum of 10 m2 → for ancillary area.
• Minimum of 25 m2 → for basic installation.
• Manufacturing & filling shall be carried out in air –
conditioned areas under aseptic condition.
• The rooms shall be further dehumidified as
considered necessary if preparation containing
antibiotics are manufactured .
35. EQUIPMETNS
1)Thermostatically controlled Hot air oven. (preferably
double ended)
2) Autoclave.
3) Air conditioning & dehumidification arrangement.
4) Laminar air flow units.
6) Automatic vial washing machine.
7) Vial drying oven.
8) Distillation unit.
9) Packaging & labeling.
10) Inspection machine.
36.
37.
38.
39.
40.
41.
42.
43.
44. PACKAGING
Plastic containers → ease of use.
→ little breakage.
→ less spoilage.
Large volume intraocular solutions of 250ml
&500ml have been packaged in glass.
Type 1 glass vials with appropriate stoppers are used
for intraocular ophthalmic products administered by
injection.
Different ophthalmic cap color coding are given by
the FDA.
45. QUALITY CONTROL SPECIFICATION
1) Raw material 2) packing material
- Description - Compatibility
- Moisture content - Stability
- Assay of ingredient
- Purity
3) In process Product
a) Mixing b) Filling
- Assay - weight variation
- Grittiness - content uniformity
- Viscosity
- Density
- pH
46. 4) Product Specification
a) Microbial specification.
- limit for total microbial count.
- Absence of specific microorganism as per pharmacopoeia.
b) Chemical specification
- pH.
- Content uniformity.
- Chemical potency.
c) Physical specification
- clarity.
- Particle size.
- Density.
- Viscosity.
47. Documentation:
1. Master formula records.
2. Batch formula records.
3. Equipment & containers records.
4. Filtration & filling records.
5. Batch Packaging & Labeling Records.
48. REFERENCES:
Remington-The science and practice of pharmacy 21 st edition
volume I.
Controlled drug delivery by N.K.Jain, Page No.(82,85,86,92,94-
96)
Indian pharmacopoeia , 2007 . vol – 1.
Controlled drug delivery by Roop K.Khar & S.P.Vyas, Page
No.(384-397,399,403)
Modern pharmaceutics edited by Gilbert S. Banker.
Pharmaceutical dosage forms parenteral medications volume 2
edited by Kenneth E. Avis, Leon Lachman .
Pharmaceutical dosage forms Disperse systems volume2
http://www.optisgroup.com/TechnologyEyegate.html.